Literature DB >> 15588658

Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus.

S M Harnett1, V Oosthuizen, M van de Venter.   

Abstract

A screening process was applied to extracts made from Sutherlandia frutescens (L.) R. Br (Fabaceae) and Lobostemon trigonus (Boraginaceae) as identified by the Botany Department, University of Port Elizabeth to detect if any of the extracts inhibited the human immunodeficiency virus (HIV). For purposes of dereplication, sulphated polysaccharides were removed and bovine serum albumin (BSA) was included in the assays to adsorb non-specific tannins potentially present. In the reverse transcriptase (RT) assay, an aqueous extract of the Lobostemon leaves inhibited HIV-1 RT with an IC50 value of 49 microg/ml, while in the protease assay no inhibition was seen. In the alpha- and beta-glucosidase assays, no significant inhibition was seen with the inclusion of BSA, indicating tannin-based inhibitory effects on these two enzymes. The beta-glucuronidase inhibitory activity, however, was retained in the presence of BSA. The study shows that Sutherlandia extracts contain inhibitory compounds active against HIV target enzymes, while aqueous Lobostemon leaf extracts contain a potent HIV-1 RT inhibitor, thus showing a potential mechanistic action of these plants in aiding HIV-positive patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15588658     DOI: 10.1016/j.jep.2004.08.038

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

1.  Sutherlandia frutescens: the meeting of science and traditional knowledge.

Authors:  Oluwaseyi M Aboyade; Gustav Styger; Diana Gibson; Gail Hughes
Journal:  J Altern Complement Med       Date:  2013-07-09       Impact factor: 2.579

2.  Cycloartane glycosides from Sutherlandia frutescens.

Authors:  Xiang Fu; Xing-Cong Li; Troy J Smillie; Paulo Carvalho; Wilfred Mabusela; James Syce; Quinton Johnson; William Folk; Mitchell A Avery; Ikhlas A Khan
Journal:  J Nat Prod       Date:  2008-09-23       Impact factor: 4.050

3.  The immunostimulatory and antimicrobial property of two herbal decoctions used in the management of HIV/AIDS in Ghana.

Authors:  George Asumeng Koffuor; Rita Dickson; Stephen Yao Gbedema; Edmund Ekuadzi; Gabriel Dapaah; Lydia Francisca Otoo
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

4.  Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats.

Authors:  Mukul Minocha; Nanda K Mandava; Deep Kwatra; Dhananjay Pal; William R Folk; Ravinder Earla; Ashim K Mitra
Journal:  Int J Pharm       Date:  2011-04-23       Impact factor: 5.875

5.  Comparison of the selected secondary metabolite content present in the cancer-bush Lessertia (Sutherlandia) frutescens L. Extracts.

Authors:  Shakira Shaik; Nisha Singh; Ashley Nicholas
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-06-01

6.  Effects of Sutherlandia frutescens extracts on normal T-lymphocytes in vitro.

Authors:  Mlungisi Ngcobo; Nceba Gqaleni; Paul K Chelule; Metse Serumula; Alain Assounga
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-10-02

7.  Sutherlandia frutescens may exacerbate HIV-associated neuroinflammation.

Authors:  Luan Dane Africa; Carine Smith
Journal:  J Negat Results Biomed       Date:  2015-07-18

8.  A randomized, double-blind, placebo-controlled trial of Lessertia frutescens in healthy adults.

Authors:  Quinton Johnson; James Syce; Haylene Nell; Kevin Rudeen; William R Folk
Journal:  PLoS Clin Trials       Date:  2007-04-27

9.  In vitro anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca.

Authors:  M Behbahani; S Sayedipour; A Pourazar; M Shanehsazzadeh
Journal:  Res Pharm Sci       Date:  2014 Nov-Dec

Review 10.  Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.

Authors:  Bahare Salehi; Nanjangud V Anil Kumar; Bilge Şener; Mehdi Sharifi-Rad; Mehtap Kılıç; Gail B Mahady; Sanja Vlaisavljevic; Marcello Iriti; Farzad Kobarfard; William N Setzer; Seyed Abdulmajid Ayatollahi; Athar Ata; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-05-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.